BAT2L1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.96560000001556E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.084370E-02 |
Normal-vs-Stage2 |
4.05549999999977E-05 |
Normal-vs-Stage3 |
6.18469719881887E-11 |
Normal-vs-Stage4 |
3.96690014170531E-10 |
Stage1-vs-Stage2 |
1.665640E-02 |
Stage1-vs-Stage3 |
1.05799999983169E-07 |
Stage1-vs-Stage4 |
3.0607000001126E-07 |
Stage2-vs-Stage3 |
2.913800E-01 |
Stage2-vs-Stage4 |
1.732960E-01 |
Stage3-vs-Stage4 |
5.758200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
9.39830000046271E-07 |
Normal-vs-AfricanAmerican |
3.734300E-02 |
Normal-vs-Asian |
5.292000E-01 |
Caucasian-vs-AfricanAmerican |
1.450380E-01 |
Caucasian-vs-Asian |
2.674200E-01 |
AfricanAmerican-vs-Asian |
6.687200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.05459999955038E-07 |
Normal-vs-Female |
3.843100E-03 |
Male-vs-Female |
3.096100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.778440E-02 |
Normal-vs-Age(41-60Yrs) |
8.828900E-04 |
Normal-vs-Age(61-80Yrs) |
1.26800000055383E-07 |
Normal-vs-Age(81-100Yrs) |
1.181550E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.084800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.771200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.430000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.414000E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.199800E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.118200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
5.105700E-02 |
Normal-vs-Grade 2 |
7.275500E-03 |
Normal-vs-Grade 3 |
5.84149950633162E-10 |
Normal-vs-Grade 4 |
5.22382137546629E-12 |
Grade 1-vs-Grade 2 |
4.976700E-03 |
Grade 1-vs-Grade 3 |
1.60999999998523E-07 |
Grade 1-vs-Grade 4 |
3.03450042871134E-10 |
Grade 2-vs-Grade 3 |
2.07569999999269E-05 |
Grade 2-vs-Grade 4 |
1.32599999869143E-08 |
Grade 3-vs-Grade 4 |
4.098100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
3.101600E-02 |
Normal-vs-ccB subtype |
3.57649999616072E-08 |
ccA subtype-vs-ccB subtype |
1.92478999999635E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.85859999996185E-06 |
Normal-vs-N1 |
7.233900E-04 |
N0-vs-N1 |
3.550800E-01 |
|
|